It's your last chance to apply for a limited number of scholarships available for people providing HCV prevention and care for people who inject drugs. This includes nurses, physicians, social workers, pharmacists, needle and syringe programme workers, counsellors, peer workers etc.
If this sounds like you and you need a helping hand to attend INHSU 2016 then click apply below!
Deadline: Friday 1 July 2016
Session B: Harm Reduction
This session starts with Johan Franck from Karolinska Institutet in Sweden giving a State-of-the-Art lecture on Opioid and Stimulant Substitution Treatment. As one of the leading experts in the field of treatment of addictive disorders, professor Franck will cover the current knowledge on opioid substitution treatment as well the more controversial topic of stimulant substitution treatment.
Holly Hagan from New York University will then give a talk on the risk of HCV transmission associated with sharing of needles and injecting equipment. She will present her own data as well as a general overview of the field, with a special focus on the prevention potential of needle and syringe programs.
Closing the session,
Mags Maher from the user organisation EuroNPUD will present the current status of harm reduction interventions across European countries, highlighting opportunities for further improvement of this work.
Sessions C and D: Parallell Oral Abstracts
Session C consists of 7 oral presentations of submitted scientific abstracts in the field of epidemiology and public health, covering a range of topics including treatment cascades, HCV transmission and HCV incidence in prisons, and network modelling among PWID.
Session D consists of 7 oral abstracts of mixed topics, including molecular epidemiology, non-invasive liver disease assessment, risk behaviours, and HCV-related fatigue.
To view the
programme visit the
conference website.
